BackgroundSouthern house mosquito Culex quinquefasciatus belongs to the C. pipiens cryptic species complex, with global distribution and unclear taxonomy. Mosquitoes of the complex can transmit human and animal pathogens, such as filarial worm, West Nile virus and avian malarial Plasmodium. Physical gene mapping is crucial to understanding genome organization, function, and systematic relationships of cryptic species, and is a basis for developing new vector control strategies. However, physical mapping was not established previously for Culex due to the lack of well-structured polytene chromosomes.MethodsInbreeding was used to diminish inversion polymorphism and asynapsis of chromosomal homologs. Identification of larvae of the same developmental stage using the shape of imaginal discs allowed achievement of uniformity in chromosomal banding pattern. This together with high-resolution phase-contrast photography enabled the development of a cytogenetic map. Fluorescent in situ hybridization was used for gene mapping.ResultsA detailed cytogenetic map of C. quinquefasciatus polytene chromosomes was produced. Landmarks for chromosome recognition and cytological boundaries for two inversions were identified. Locations of 23 genes belonging to 16 genomic supercontigs, and 2 cDNA were established. Six supercontigs were oriented and one was found putatively misassembled. The cytogenetic map was linked to the previously developed genetic linkage groups by corresponding positions of 2 genetic markers and 10 supercontigs carrying genetic markers. Polytene chromosomes were numbered according to the genetic linkage groups.ConclusionsThis study developed a new standard cytogenetic photomap of the polytene chromosomes for C. quinquefasciatus and was applied for the fine-scale physical mapping. It allowed us to infer chromosomal position of 1333 of annotated genes belonging to 16 genomic supercontigs and find orientation of 6 of these supercontigs; the new cytogenetic and previously developed genetic linkage maps were integrated based on 12 matches. The map will further assist in finding chromosomal position of the medically important and other genes, contributing into improvement of the genome assembly. Better assembled C. quinquefasciatus genome can serve as a reference for studying other vector species of C. pipiens complex and will help to resolve their taxonomic relationships. This, in turn, will contribute into future development of vector and disease control strategies.Electronic supplementary materialThe online version of this article (doi:10.1186/s13071-015-0912-4) contains supplementary material, which is available to authorized users.
Introduction A 52-year-old man presented with extensive bilateral inflammatory myositis of the quadriceps on a background of pyrexia of unknown origin (PUO). He had markedly elevated acute phase reactants but had a normal CK and did not develop muscle weakness. This was a transient phenomenon which resolved spontaneously over 10 weeks. There was not an infective process identified and he was not treated with glucocorticoids or other immunosuppressants. This case highlights the importance of careful consideration of steroid treatment in atypical presentations without a clear diagnosis and the value of multidisciplinary involvement in patient care. Case description The patient presented with a 2-week history of acute onset bilateral thigh pain, stiffness and persistent fevers following an episode of alcohol intake although symptoms may have preceded this. Myalgia was a prominent feature however he maintained full power of the hip flexors and all other proximal and distal muscle groups. No skin changes, swallow or respiratory symptoms. CK was normal at presentation and remained low. Acute phase reactants were elevated including CRP 405mg/L, ESR 110mm/hr. Platelets 1000x109/L, WCC 17.7x109/L. Urinalysis and renal function normal. ALT raised at 136U/L. AST normal, other liver parameters raised in keeping with acute phase response. No previous episodes, no preceding travel, infection, bites, illicit drugs or family history of muscle disorders. He was taking a statin which was discontinued. PUO work up including cultures, viral titres, echocardiogram and CT imaging did not identify a source. Empiric antibiotics were trialled without improvement. ANA, ANCA and myositis panels were negative. MRI of thighs reported extensive inflammatory myositis involving the quadriceps bilaterally with mild involvement of biceps femoris. There were no features of an infected collection or rhabdomyolysis. Muscle biopsy showed a lymphocytic myositis with neurogenic atrophy. Differential included idiopathic inflammatory myositis (IIM) spectrum with viral myositis felt less likely. Clinically he remained sore but improving and mobilising. Daily pyrexias persisted but he remained fully strong with a low normal CK and a downward trend in inflammatory markers. Investigations for occult malignancy including CTPET and bone marrow biopsy were negative. Steroid treatment was not instigated. A watchful waiting approach was taken and his symptoms and blood investigations gradually improved. He embarked on a physiotherapist guided exercise programme. Follow up MRI at 10 weeks showed complete resolution of the inflammatory features. Discussion This is a case of an acute onset myositis with systemic inflammatory features which resolved spontaneously. Differential diagnoses including inherited, metabolic and toxic myopathies were considered and discounted. Although alcohol had been taken and he had been taking a statin prior to onset, the clinical picture, normal CK and biopsy findings did not support these as likely culprits. Extensive viral and serology infective tests were negative and the exact cause was not identified. The clinical features strongly mimicked an idiopathic inflammatory myositis (IIM) however atypical features including normal CK and lack of objective weakness led to continued doubt of an autoimmune aetiology. Additionally there were no upper limb or neck flexor symptoms and no extra-muscular manifestations. Applying the ACR/EULAR 2017 criteria for IIM to this case the probability of this diagnosis is 5% although this does not take into account the radiological findings. With evidence of inflammatory myositis and a dramatic acute phase response including persistent pyrexia there was a strong temptation to begin steroid therapy. His case was discussed with radiology, pathology and neurology and ultimately the decision to withhold was justified. In this case improvement would have occurred with steroid which would likely have led to an incorrect diagnosis of IIM and the patient would have been unnecessarily treated with prolonged high dose steroid and disease modifying drugs with the associated side effects and long term sequelae. Key learning points This case highlights the importance of confirming a diagnosis prior to initiating steroid therapy particularly if there are atypical features. Glucocorticoids would undoubtedly have led to a clinical improvement however this would have given rise to a misdiagnosis and unnecessary long term immunosuppression. There were many positive test results for inflammation including blood, imaging and muscle tissue but ultimately the clinical examination findings, particularly the absence of weakness, were consistent and the basis of the rationale to withhold steroid treatment. As clinical improvement progressed with supportive management this decision was justified. This demonstrates the importance of patient centred care and the value of the clinical examination. This was an unusual case therefore input and advice was sought from colleagues in neurology, neuropathology, rheumatology and radiology. This was vital to clinical care decisions and emphasizes the importance of a multidisciplinary approach in complex cases. Despite extensive investigations no cause was identified for this transient inflammatory myositis. This highlights the unknown elements within this spectrum of disease and the need for ongoing reporting of atypical cases. Conflicts of interest The authors have declared no conflicts of interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.